⌘K

Login Start Free

Home/Filings/4/0000950170-24-012167

4//SEC Filing

Ciulla Thomas 4

Accession 0000950170-24-012167

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:01 PM ET

Size

5.6 KB

Accession

0000950170-24-012167

Insider Transaction Report

Form 4

Period: 2024-02-05

Viridian Therapeutics, Inc.\DEVRDN

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2024-02-05+50,000→ 50,000 total
Exercise: $18.70Exp: 2034-02-05→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in 48 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001815426

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 4:01 PM ET
Size: 5.6 KB

View on SEC.gov